Select Funding Opportunities
Click here to visit the NCI grant site.
Use your device's search function to find a specific disease or funding source.
Funding
The fund will facilitate the advancement of innovative basic science, translational or clinical research to advance the understanding and treatment of Myelodysplastic Syndromes (MDS) and related blood disorders (such as MDS/myeloproliferative neoplasms (MPN) overlap syndromes, secondary acute myeloid leukemia following MDS, idiopathic cytopenia of undetermined significance (ICUS), or clonal hematopoiesis of indeterminate potential (CHIP).
The foundation will consider proposals from individuals at university, college, hospital, or laboratory institutions for support of research in MDS or related disorders in two types:
- Early Career Awards
- Established Investigator Awards
Letter of Intent (LOI) Deadline: LOIs are accepted on a rolling basis.
Learn More>>
- Victoria’s Secret Global Fund for Women’s Cancers 2022 Career Development Award, in partnership with Pelotonia & AACR - Application Deadline: June 28, 2022
- AACR-Day One Biopharmaceuticals Pediatric Cancer Research Fellowship - Application Deadline: July 6, 2022
DoD Breast Cancer Research Program Awards
These awards provide funding to support innovative, high-impact research with clinical relevance that will accelerate progress to end breast cancer for Service Members, Veterans, and the general public.
- Breakthrough Award Levels 1 and 2- LOI Due: September 22, 2022
- Breakthrough Award Level 3- Pre-application Due: August 3, 2022
- Breakthrough Award Level 4- Pre-application Due: August 3, 2022
- Era of Hope Scholar Award- LOI Due: September 22, 2022
- Innovator Award- LOI Due: August 3, 2022
Learn more about the DoD BCRP>>
DoD Ovarian Cancer Research Program Clinical Trial Award
This award supports the rapid implementation of clinical trials with the potential to have a significant impact on the treatment or management of ovarian cancer.
Application Deadline: August 5, 2022
Learn more about the DoD OCRP award>>
DoD Rare Cancers Research Program Awards
There are a significant number of incidences of rare cancers in the U.S. military population. Over 60 forms of cancer disproportionately impact those who have served in the military, and 67% of them are rare cancers. These awards support research on the prevention, detection, diagnosis, and treatment of Service Members, Veterans, their families, and the American public.
- Concept Award- Application Deadline: August 29, 2022
- Idea Development Award- Application Deadline: September 30, 2022
- Resource and Community Development Award- Application Deadline: September 30, 2022
Learn more about the DoD RCRP>>
DoD Kidney Cancer Research Program (KCRP)
These awards support research of exceptional scientific merit in the area of kidney cancer.
- Academy of Kidney Cancer Investigators Early-Career Scholar Award- LOI Due: September 29, 2022
- Nurse-Initiated Research Award- LOI Due: September 29, 2022
- Clinical Trial Award- LOI Due: September 29, 2022